FORTRESS BIOTECH INC - COM (FBIO)

CUSIP: 34960Q109

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
28,425,069
Share change
+268,557
Total reported value
$23,306,552
Put/Call ratio
18%
Price per share
$0.82
Number of holders
51
Value change
+$426,105
Number of buys
24
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 34960Q109?
CUSIP 34960Q109 identifies FBIO - FORTRESS BIOTECH INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FORTRESS BIOTECH INC - COM (FBIO) as of Q1 2023

As of 31 Mar 2023, FORTRESS BIOTECH INC - COM (FBIO) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,425,069 shares. The largest 10 holders included Nantahala Capital Management, LLC, VANGUARD GROUP INC, Opaleye Management Inc., Jefferies Financial Group Inc., PERKINS CAPITAL MANAGEMENT INC, BlackRock Inc., SHIKIAR ASSET MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, CI Private Wealth, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 51 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.